An enzyme associated with extensive antibiotic resistance called New Delhi metallo-ß-lactamase-1 (NDM-1) has been found in two people in the Toronto area, says case report
![Report Says New Delhi Metallo-beta-lactamase-1 Enzyme Acquired in Canada Report Says New Delhi Metallo-beta-lactamase-1 Enzyme Acquired in Canada](https://www.medindia.net/afp/images/Britain-health-science-offbeat-38432.jpg)
NDM-1 has spread because of worldwide travel, medical tourism and its ability to transfer between bacteria.
In one of the cases in this report, the patient had not travelled outside southwestern Ontario in over a decade, and no source could be identified for the organism. In the other case, the patient had been hospitalized in India for a medical procedure and acquired the organism there.
"These two scenarios show that local acquisition of an organism producing NDM-1 has already occurred in Ontario, Canada, that blaNDM-1 has been found in bacterial species other than [Escherichia coli] and [Klebsiella pneumoniae], that treatment options are limited for infections with NDM-1-producing organisms, and that the detection of NDM-1-producing organisms by a laboratory can be difficult," writes Dr. Susan Poutanen, Mount Sinai Hospital and University Health Network, with coauthors.
In the case of the patient who had not travelled, the authors note: "To the best of our knowledge, this is the first reported instance in which an NDM-1-producing organism was locally acquired in Canada."
In cases where patients are infected with NDM-1, extensive infection control precautions must be taken, including isolation in single rooms and enhanced cleaning.
Advertisement
Laboratory detection of the pathogen is also difficult, and labs should adopt different screening procedures.
Advertisement
Source-Eurekalert